Bullish vs. Bearish (1 opinions)
Social Sentiment 0.00
TNDM Forecast and Technical Stock Analysis
Sell candidate since 2019-08-14 Loss -1.69%
Tandem Diabetes Care gained 2.89% in the last trading day ( Friday, 16th Aug 2019 ), rising from $57.11 to $58.76 During the day the stock fluctuated 2.93% from a day low at $57.34 to a day high of $59.02. The price has been going up and down for this period, and there has been a -9.96% loss for the last 2 weeks. Volume fell in the last day by -704 987 shares and in total, 944 510 shares bought and sold for approximately $55.50 million. You should take into consideration that a falling volume on higher prices causes divergence and may be an early warning about possible changes for the next couple of days.
- 30 day high of the TNDM stock price was $70.19 and low was $56.69.
- 90 day high was $72.03 and low was $56.69.
- 52 week high for Tandem Diabetes Care - $74.81 and low - $26.40.
Tandem Diabetes Care lies in the middle of a wide and falling trend in the short term and further fall within the trend is signaled. Given the current short-term trend, the stock is expected to fall -10.08% during the next 3 months and, with 90% probability hold a price between $50.60 and $59.30 at the end of this period.
A buy signal was issued from a pivot bottom point on Thursday August 15, 2019, which indicates further gains until a new top pivot has been found. Volume fell during the last trading day despite gaining prices. This causes a divergence between volume and price and it may be an early warning. The stock should be watched closely. Some negative signals were issued as well, and these may have some influence on the near short-term development. Tandem Diabetes Care holds sales signals from both short- and long-term moving averages. In addition, there is a general sales signal from the relation between the two signals where the long-term average is above the short-term average. On corrections up there will be some resistance from the lines at $61.19 and $63.06. A break-up above any of these levels will issue buy signals.
Relative Strength Index (RSI)
RSImin/max Values: [ 25 - 75 ]
RSI14 is 45 and the stock is currently not being overbought or oversold
* Stockinvest.us uses dynamical calculated RSI max/min levels to determine when stock is oversold or overbought based on historical behaviour.
Support & Resistance
Tandem Diabetes Care finds support from accumulated volume at $57.11.
This stock is usually traded at a good volume, and with minor daily changes, the risk is considered to be low. During the last day, the stock moved $1.68 (2.93%) between high and low. For the last week, the stock has had daily average volatility of 4.59%.
Our recommended stop-loss: We hold a sell evaluation for this stock. No stop-loss set.
4.59 %Average volatility
Very Low Low Medium High Very High
Tandem Diabetes Care holds several negative signals and is within a wide and falling trend, so we believe it will still perform weakly in the next couple of days or weeks. We therefore hold a negative evaluation of this stock. We have upgraded our recommendation for this stock since last evaluation from a Strong Sell Candidate to a Sell Candidate.
|TNDM $58.76 ($1.65 2.89%)|
TNDM is up $1.65 today, but where's it headed in 2019?
|Zacks Investment Research is releasing its prediction for TNDM based on the 1-3 month system that more than doubles the S&P 500.
This report is free today for StockInvest.us readers.
Click here – the TNDM analysis is free »
Golden Star Signal
This unique signal uses moving averages and adds special requirements that convert the very good Golden Cross into a Golden Star.
This signal is rare and, in most cases, gives substantial returns. From 8.000 stocks usually only a few will trigger a Golden Star Signal per day!